Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1
Cancer Immunology, Immunotherapy · 2023
DOI: 10.1007/s00262-023-03501-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2023. Verfasst von Wenjie Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND: Disruptions in lipid metabolism and amino acids have been increasingly linked to resistance to immunotherapy. However, the underlying mechanisms by which dysregulated serum lipid metabolism and amino acids affect the efficacy of immunotherapies through PD-1/PD-L1 expression and function remain poorly understood. METHODS: To elucidate the potential associations between lipid metabolism, amino acids, and PD-1/PD-L1, we employed the powerful Mendelian randomization (MR) method, leveraging large-scale genome-wide association studies. RESULTS: In the present MR study, we identified a noteworthy negative association between alanine and PD-1 expression, implicating a regulatory role for alanine metabolism in modulating the immune response to cancer treatment. Additionally, we elucidated fourteen specific lipid metabolism biomarkers that were significantly linked to PD-L1 expression, including cholesterol and triglycerides. Glutamine and phenylalanine were also found to showcase an intriguing causal association with the expression of PD-L1. Eventually, we confirmed the potential roles of key genes involved in lipid and amino acids metabolism in influencing the response to immunotherapy. CONCLUSIONS: These findings provided new insights into the role of lipid metabolism as well as amino acids in regulating PD-1/PD-L1, suggesting that strategies targeting lipid and amino acid metabolisms may have therapeutic potential for improving the efficacy of immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
- Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. wwei9500@smu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Li, W., & Wang, W. (2023). Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03501-8
Vancouver
Li W, Wang W. Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1. Cancer Immunology, Immunotherapy. 2023. doi:10.1007/s00262-023-03501-8
BibTeX
@article{Li2023,
author = {Li, Wenjie and Wang, Wei},
title = {Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1},
journal = {Cancer Immunology, Immunotherapy},
year = {2023},
doi = {10.1007/s00262-023-03501-8}
}
EUVIMED